SDC1 and neoplasm: Preclinical study on TNBC xenograft mice by Rousseau et al., [76] demonstrates good visualization of TNBC tumor with Iodine-124 (124I) labeled B-B4 antibody (targeting syndecan-1; CD138 antigen) and experience good response (treatment) with I-131 (131I) radiolabelled B-B4 antibody.